Coya Therapeutics, Inc. · NASDAQ:COYA
Dr. Reddy's Laboratories, Inc. reported a 9.70% stake in Coya Therapeutics, Inc. (Schedule 13G)
Event Jan 30, 2026 · Filed Mar 12, 2026
Dr. Reddy's Laboratories, Inc. reported a 9.70% stake in Coya Therapeutics, Inc., 2,272,727 shares, as a passive investor on Jan 30, 2026. Filed Mar 12, 2026 (Schedule 13G).
- Stake
- 9.70%
- Shares
- 2,272,727
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Dr. Reddy's Laboratories, Inc. | 9.70% | 2,272,727 |
| Dr. Reddy's Laboratories SA | 9.70% | 2,272,727 |
| Dr. Reddy's Laboratories Limited | 9.70% | 2,272,727 |
Source
Related
- Coya Therapeutics, Inc.
- Dr. Reddy's Laboratories, Inc.
- Coya Therapeutics, Inc. shareholders
- Schedule 13G/A · Orin Hirschman · Jul 27, 2026
- Schedule 13G/A · The Vanguard Group · Jan 30, 2026
- Schedule 13G/A · Orin Hirschman · Jan 28, 2026
- Schedule 13G/A · DME Capital Management, LP · Feb 14, 2025
- Schedule 13G/A · Orin Hirschman · Feb 10, 2025